Skip to main content
. 2019 Jan 17;38(19):3551–3568. doi: 10.1038/s41388-018-0659-4

Table 3.

Cell surface proteins overexpressed in cancer cells

Preferentially overexpressed in HPV+ HNSCC
genes mean of expression controls mean of expression HPV+ fold change HPV+/controls FDR mean of expression HPV- fold change HPV-/controls FDR
ITGAM 70.80 370.67 5.24 5.24E-04 19.24 0.27 5.11E-01
VCAM1 169.55 4133.39 24.38 8.23E-24 0.00 0.00 2.79E-01
TMEM26 5.16 27.92 5.41 2.20E-06 4.67 0.91 9.34E-01
NTN3 1.55 10.54 6.81 2.27E-13 1.87 1.21 6.75E-01
PDCD1LG2 63.14 259.03 4.10 3.89E-06 58.76 0.93 7.18E-01
PON1 0.90 3.23 3.57 1.15E-03 0.66 0.73 7.24E-01
ADAM22 8.12 58.64 7.22 1.39E-09 12.89 1.59 4.23E-01
SLC12A5 1.51 9.51 6.29 7.36E-14 2.59 1.72 8.83E-02
CRB2 20.66 187.34 9.07 7.13E-18 6.69 0.32 9.55E-02
ITGA2B 8.70 50.16 5.77 5.06E-24 17.67 2.03 4.56E-05
OLFM1 267.08 2961.37 11.09 1.02E-13 758.81 2.84 9.61E-03
ZP4 0.58 3.40 5.82 1.61E-04 1.65 2.82 9.25E-02
CELSR3 118.58 737.21 6.22 2.82E-37 304.07 2.56 3.04E-10
ROR2 94.70 522.15 5.51 1.54E-08 289.49 3.06 6.37E-04
CLEC1A 22.28 124.37 5.58 3.69E-05 72.79 3.27 1.98E-02
ICAM1 578.30 3194.41 5.52 1.09E-02 1384.93 2.39 4.35E-01
PTGIR 15.28 86.87 5.68 5.89E-07 13.63 0.89 9.18E-01
Preferentially overexpressed in HPV- HNSCC
genes mean of expression controls mean of expression HPV- fold change HPV-/controls FDR mean of expression HPV+ fold change HPV+/controls FDR
ALPP 0.61 31.28 51.34 2.41E-125 0.00 0.00 9.22E-01
NT5E 213.94 1257.01 5.88 1.75E-04 387.26 1.81 5.03E-01
SGCZ 0.26 2.10 8.13 2.25E-02 0.20 0.76 9.76E-01
IL13RA2 21.29 94.73 4.45 4.85E-06 21.58 1.01 1.00E+00
ODZ1 0.22 56.86 254.91 4.79E-06 0.00 0.00 1.00E+00
PTPRD 77.15 283.72 3.68 1.10E-04 40.38 0.52 4.50E-01
BCHE 27.30 111.63 4.09 8.96E-04 3.02 0.11 3.10E-01
ORM1 0.58 8.63 14.95 8.47E-06 0.00 0.00 7.47E-01
NTSR1 9.37 62.44 6.67 1.10E-39 1.78 0.19 3.80E-04
FBN2 212.38 1626.51 7.66 5.89E-15 426.47 2.01 1.80E-02
FGFR4 46.56 200.06 4.30 2.94E-05 107.51 2.31 5.09E-02
HTR1D 2.40 29.31 12.22 5.25E-14 3.83 1.60 3.79E-01
TFPI2 38.36 357.56 9.32 9.91E-13 0.00 0.00 1.54E-01
MDGA1 141.13 490.76 3.48 7.56E-07 143.25 1.02 1.00E+00
NXF2 13.20 67.24 5.09 1.12E-10 0.00 0.00 1.48E-02
MMP13 159.86 4039.67 25.27 7.03E-46 322.68 2.02 6.61E-02
PCDHGB1 33.00 121.46 3.68 5.06E-10 13.96 0.42 2.58E-02
PROCR 175.03 899.66 5.14 2.08E-08 440.34 2.52 3.15E-03
F2 0.30 5.53 18.65 9.83E-47 0.00 0.00 1.33E-01
CDH4 5.15 41.35 8.03 1.53E-04 0.00 0.00 5.65E-01
ITIH2 0.21 1.22 5.91 4.05E-04 0.00 0.00 4.65E-01
TSPAN18 265.29 872.08 3.29 2.50E-03 272.16 1.03 1.00E+00
PTGS2 256.78 2080.61 8.10 4.12E-06 1050.23 4.09 1.41E-02
CLEC12A 0.56 33.17 59.74 6.14E-05 2.11 3.81 8.65E-01
CD70 2.98 90.85 30.52 1.32E-07 50.91 17.11 5.52E-03
SDK1 145.67 1152.86 7.91 2.50E-03 619.05 4.25 1.36E-01
ABCC2 13.09 59.09 4.51 4.73E-04 1.75 0.13 3.59E-01
Overexpressed in both HPV+ and HPV- HNSCC
genes mean of expression controls mean of expression HPV+ fold change HPV+/controls FDR mean of expression HPV- fold change HPV-/controls FDR
CHST7 60.94 213.32 3.50 4.01E-09 289.09 4.74 2.77E-11
TMEM200B 55.56 177.05 3.19 5.43E-06 184.94 3.33 2.78E-06
NXPH4 271.45 910.32 3.35 3.39E-03 878.77 3.24 4.89E-03
COL11A1 32.91 282.92 8.60 3.56E-02 235.69 7.16 7.99E-02
MGAT5B 5.92 44.42 7.50 5.46E-07 35.85 6.05 2.23E-05
LY6K 434.86 1471.16 3.38 1.27E-14 1458.68 3.35 1.24E-11
ICAM5 20.12 109.12 5.42 2.65E-16 101.61 5.05 1.14E-11
EPHB2 132.77 537.62 4.05 7.53E-05 594.52 4.48 1.64E-05
PLAU 805.67 3685.90 4.57 2.04E-07 5178.89 6.43 7.24E-10